TREATMENTS OF RADIOIODINE- REFRACTORY DIFFERENTIATED THYROID CANCER IN ROUTINE CLINICAL PRACTICE - A SYSTEMATIC REVIEW

被引：0
|
作者：
Bhutani, M. K. [1 ]
Rajora, P. [1 ]
Soni, D. [1 ]
Pan, J. J. [2 ]
机构：
[1] BresMed Hlth Solut India Pvt Ltd, Gurugram, India
[2] Eisai Inc, Woodcliff Lake, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.088
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN5
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [21] Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib
    Kawalec, Pawel
    Malinowska-Lipien, Iwona
    Brzostek, Tomasz
    Kozka, Maria
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1303 - 1309
  • [22] Radioiodine in differentiated thyroid cancer
    Borner, AR
    MullerGartner, HW
    [J]. ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (04): : 274 - 285
  • [23] Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
    Tumino, Dario
    Frasca, Francesco
    Newbold, Kate
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [24] Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer
    Hewett, Yvonne
    Ghimire, Subash
    Farooqi, Bilal
    Shah, Binay K.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 28 - 32
  • [25] THE EVPI OF TREATMENT STRATEGIES FOR RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Huang, W.
    Chen, L.
    Ting, J.
    Cao, V
    Sung, H.
    Yokokura, M.
    Wilson, L.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A886 - A886
  • [26] Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
    Fabian Pitoia
    Rafael Selbach Scheffel
    Ines Califano
    Alicia Gauna
    Hernán Tala
    Fernanda Vaisman
    Alejandro Roman Gonzalez
    Ana Oliveira Hoff
    Ana Luiza Maia
    [J]. Reviews in Endocrine and Metabolic Disorders, 2024, 25 : 109 - 121
  • [27] Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
    Pitoia, Fabian
    Scheffel, Rafael Selbach
    Califano, Ines
    Gauna, Alicia
    Tala, Hernan
    Vaisman, Fernanda
    Gonzalez, Alejandro Roman
    Hoff, Ana Oliveira
    Maia, Ana Luiza
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01): : 109 - 121
  • [28] Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
    Capdevila, Jaume
    Deandreis, Desiree'
    Durante, Cosimo
    Leboulleux, Sophie
    Luster, Markus
    Netea-Maier, Romana
    Newbold, Kate
    Singer, Susanne
    Sykiotis, Gerasimos P.
    Bartes, Beate
    Farnell, Kate
    Locati, Laura Deborah
    [J]. EUROPEAN THYROID JOURNAL, 2023, 12 (05)
  • [29] Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients
    Saie, C.
    Wassermann, J.
    Mathy, E.
    Chereau, N.
    Leenhardt, L.
    du Montcel, S. Tezenas
    Buffet, C.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (05) : 667 - 676
  • [30] Role of laser ablation in multimodal treatment of radioiodine- refractory bone metastases of thyroid cancer: a retrospective study
    Pacella, Claudio Maurizio
    Di Stasio, Enrico
    Guglielmi, Rinaldo
    Baroli, Alberto
    Pedrazzini, Luca
    Misischi, Irene
    Persichetti, Agnese
    Papini, Enrico
    [J]. ENDOCRINE, 2020, 70 (02) : 338 - 347
12345